Carlos Azuaje

411 total citations
9 papers, 200 citations indexed

About

Carlos Azuaje is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Carlos Azuaje has authored 9 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in Carlos Azuaje's work include HIV/AIDS drug development and treatment (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Carlos Azuaje is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Carlos Azuaje collaborates with scholars based in Spain, Palestinian Territory and France. Carlos Azuaje's co-authors include Albert Pahissa, Esteban Ribera, Leonor Pou, Rosa María López, I Ocaña, Manuel Crespo, Vicenç Falcó, María Feijoo-Cid, Adrián Curran and Isabel Ruíz-Camps and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, AIDS and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Carlos Azuaje

9 papers receiving 179 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Azuaje Spain 8 177 79 58 46 27 9 200
Guglielmo Marco Migliorino Italy 10 106 0.6× 56 0.7× 50 0.9× 34 0.7× 12 0.4× 20 201
Chiara Montrucchio Italy 9 126 0.7× 63 0.8× 83 1.4× 41 0.9× 15 0.6× 14 211
Betsy Smith United States 7 173 1.0× 101 1.3× 68 1.2× 39 0.8× 42 1.6× 11 218
J Lange Netherlands 9 193 1.1× 147 1.9× 55 0.9× 56 1.2× 6 0.2× 17 248
Yoninah Cramer United States 9 211 1.2× 98 1.2× 130 2.2× 32 0.7× 36 1.3× 17 345
Amina Carlebach Germany 11 346 2.0× 255 3.2× 132 2.3× 66 1.4× 20 0.7× 15 432
Ilaria Caramma Italy 10 107 0.6× 92 1.2× 129 2.2× 17 0.4× 13 0.5× 14 245
Ottavia Viganò Italy 8 106 0.6× 52 0.7× 33 0.6× 13 0.3× 19 0.7× 21 160
Annemie Buelens Belgium 10 268 1.5× 93 1.2× 234 4.0× 32 0.7× 36 1.3× 19 438
Beatriz Larrú United States 8 93 0.5× 30 0.4× 43 0.7× 17 0.4× 15 0.6× 20 185

Countries citing papers authored by Carlos Azuaje

Since Specialization
Citations

This map shows the geographic impact of Carlos Azuaje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Azuaje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Azuaje more than expected).

Fields of papers citing papers by Carlos Azuaje

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Azuaje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Azuaje. The network helps show where Carlos Azuaje may publish in the future.

Co-authorship network of co-authors of Carlos Azuaje

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Azuaje. A scholar is included among the top collaborators of Carlos Azuaje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Azuaje. Carlos Azuaje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Azuaje, Carlos, Aída González-Díaz, Juan Pablo Horcajada, et al.. (2022). A Descriptive Analysis of Urinary ESBL-Producing-Escherichia coli in Cerdanya Hospital. Microorganisms. 10(3). 488–488. 5 indexed citations
2.
Ribera, Esteban, Carlos Azuaje, Rosa María López, et al.. (2007). Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis. Journal of Antimicrobial Chemotherapy. 59(4). 690–697. 36 indexed citations
3.
Ribera, Esteban, Carlos Azuaje, Rosa María López, et al.. (2006). Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen. AIDS. 20(8). 1131–1139. 39 indexed citations
4.
Azuaje, Carlos, Núria Fernández-Hidalgo, Benito Almirante, et al.. (2006). Meningitis tuberculosa: estudio comparativo en relación con la coexistencia de infección por el virus de la inmunodeficiencia humana. Enfermedades Infecciosas y Microbiología Clínica. 24(4). 245–250. 12 indexed citations
5.
Ribera, Esteban, Carlos Azuaje, Rosa María López, et al.. (2005). Once-Daily Regimen of Saquinavir, Ritonavir, Didanosine, and Lamivudine in HIV-Infected Patients With Standard Tuberculosis Therapy (TBQD Study). JAIDS Journal of Acquired Immune Deficiency Syndromes. 40(3). 317–323. 22 indexed citations
6.
Casado, Alfonso, Xavier Badı́a, Elena Ferrer, et al.. (2004). Health-Related Quality of Life in HIV-Infected Naive Patients Treated with Nelfinavir or Nevirapine Associated with ZDV/3TC (the COMBINE-QoL Substudy). HIV Clinical Trials. 5(3). 132–139. 14 indexed citations
7.
Ribera, Esteban, Rosa María López, Leonor Pou, et al.. (2004). Steady-State Pharmacokinetics of a Double-Boosting Regimen of Saquinavir Soft Gel plus Lopinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Infected Adults. Antimicrobial Agents and Chemotherapy. 48(11). 4256–4262. 52 indexed citations
8.
Gavaldà, Joan, Xavier Gomis, José Luis Ramírez, et al.. (2002). Efficacy of Ceftriaxone and Gentamicin Given Once a Day by Using Human-Like Pharmacokinetics in Treatment of Experimental Staphylococcal Endocarditis. Antimicrobial Agents and Chemotherapy. 46(2). 378–384. 8 indexed citations
9.
Gavaldà, Joan, Benito Almirante, Xavier Gomis, et al.. (2001). Efficacy of Teicoplanin-Gentamicin Given Once a Day on the Basis of Pharmacokinetics in Humans for Treatment of Enterococcal Experimental Endocarditis. Antimicrobial Agents and Chemotherapy. 45(5). 1387–1393. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guglielmo Marco Migliorino Breakdown of academic impact, for papers by Chiara Montrucchio Breakdown of academic impact, for papers by Betsy Smith Breakdown of academic impact, for papers by J Lange Breakdown of academic impact, for papers by Yoninah Cramer Breakdown of academic impact, for papers by Amina Carlebach Breakdown of academic impact, for papers by Ilaria Caramma Breakdown of academic impact, for papers by Ottavia Viganò Breakdown of academic impact, for papers by Annemie Buelens Breakdown of academic impact, for papers by Beatriz Larrú
Rankless by CCL
2026